These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 28074314)

  • 21. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines.
    Cakir Y; Plummer HK; Tithof PK; Schuller HM
    Int J Oncol; 2002 Jul; 21(1):153-7. PubMed ID: 12063562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta2-adrenergic receptor signaling mediates corneal epithelial wound repair.
    Ghoghawala SY; Mannis MJ; Pullar CE; Rosenblatt MI; Isseroff RR
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1857-63. PubMed ID: 18436820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.
    Cheng G; Weihua Z; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3739-46. PubMed ID: 14762170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells.
    Lecomte S; Chalmel F; Ferriere F; Percevault F; Plu N; Saligaut C; Surel C; Lelong M; Efstathiou T; Pakdel F
    Cell Commun Signal; 2017 Jun; 15(1):26. PubMed ID: 28666461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
    Sampayo R; Recouvreux S; Simian M
    Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression.
    Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N
    J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer.
    Wu X; Chen F; Sahin A; Albarracin C; Pei Z; Zou X; Singh B; Xu R; Daniels G; Li Y; Wei J; Blake M; Schneider RJ; Cowin P; Lee P
    Breast Cancer Res Treat; 2011 Jul; 128(2):391-400. PubMed ID: 20814820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen metabolites and breast cancer.
    Santen RJ; Yue W; Wang JP
    Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between β2- and α2-Adrenergic Receptors in the Regulation of B16F10 Melanoma Cell Proliferation.
    Matarrese P; Maccari S; Ascione B; Vona R; Vezzi V; Stati T; Grò MC; Marano G; Ambrosio C; Molinari P
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells.
    Chen H; Zhang W; Cheng X; Guo L; Xie S; Ma Y; Guo N; Shi M
    Cancer Sci; 2017 Jul; 108(7):1310-1317. PubMed ID: 28498637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
    Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
    O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
    Abukhdeir AM; Blair BG; Brenner K; Karakas B; Konishi H; Lim J; Sahasranaman V; Huang Y; Keen J; Davidson N; Vitolo MI; Bachman KE; Park BH
    Breast Cancer Res Treat; 2006 Sep; 99(1):23-33. PubMed ID: 16541319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse.
    Kenney NJ; Bowman A; Korach KS; Barrett JC; Salomon DS
    Breast Cancer Res Treat; 2003 May; 79(2):161-73. PubMed ID: 12825851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals.
    Bruzzone A; Saulière A; Finana F; Sénard JM; Lüthy I; Galés C
    FASEB J; 2014 Mar; 28(3):1342-54. PubMed ID: 24308976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.